Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 2 1

Status

Completed 3

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 2Choledocholithiasis 2Pancreatitis 1Pain 1Choledochal Cyst 1Cholangitis 1Cholangiocarcinoma 1Agnosia 1

Interventions

Cyclophosphamide 956Radiotherapy 847Cisplatin 757Gemcitabine 657Carboplatin 603Docetaxel 598Paclitaxel 585Bevacizumab 580Fluorouracil 504Oxaliplatin 458Rituximab 453Surveys and Questionnaires 449Capecitabine 440Dexamethasone 428Doxorubicin 424Etoposide 411Irinotecan 389Cytarabine 376Filgrastim 369pembrolizumab 328Leucovorin 305Nivolumab 296fludarabine phosphate 294Melphalan 288Magnetic Resonance Spectroscopy 280Peripheral Blood Stem Cell Transplantation 279Blood Specimen Collection 279Methotrexate 276Lenalidomide 276Cetuximab 270

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × OTHER × Meperidine × Clear all
NCT06111872 2025-03-25

Ketamine-midazolam as a Sedative Agent in Endoscopic Retrograde Cholangiopancreatography.

National University of Malaysia

Phase 2 Completed
90 enrolled
Gastrointestinal

Cholangitis, Pancreatic Neoplasms, Choledochal Cyst, Choledocholithiasis

NCT02684942 2017-06-01

Comparison of Meperidine and Fentanyl on Pain Scale and QOL in Brachytherapy

Chulabhorn Cancer Center

Phase 4 Completed
40 enrolled 11 charts

Agnosia, Pain

NCT02027311 2015-06-29

Etomidate vs. Midazolam for Sedation During ERCP

Cheju Halla General Hospital

Phase 4 Completed
63 enrolled 9 charts
Gastrointestinal

Pancreatic Neoplasms, Pancreatitis, Cholangiocarcinoma, Choledocholithiasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡